
Bio Implants Market Report and Forecast 2025-2034
Description
The global bio implants market size was valued at USD 122.80 Billion in 2024, driven by the rising demand of implants in managing cardiovascular diseases and orthopedic disorders across the globe. The market is expected to grow at a CAGR of 9.56% during the forecast period of 2025-2034, with the values likely to rise from to USD 306.00 Billion by 2034.
Global Bio Implants Market Overview
Biomedical implants or bio implants are medical devices injected or surgically implanted into the body to support, repair, replace, or enhance the existing biological structure. According to the World Health Organisation (WHO), chronic diseases account for 41 million deaths annually. The rising burden of chronic diseases is anticipated to bolster the market growth in the future. In addition, technical advancements such as advent of biocompatible materials, surge in research initiatives, as well as increasing application of bioimplants in multiple domains including cardiology, neurology and dentistry among others is projected to bolster the bio implants market growth in the forecast period.
In October 2023, Evonik introduced an innovative carbon-fiber reinforced PEEK filament to be used in 3D printing of medical implants. VESTAKEEP® filament featured 12% and 20% carbon fiber content, offering high strength, flexibility and ductility. Applied as 3D medical implants, it can be used in bone plates and other reconstructive prostheses. Growing utilisation of smart materials in developing compatible, lightweight, and durable implants in one of the most significant trends in the market, helping to curb the rising bio implants market demand.
In recent years, technical advancements and a better understanding of human anatomy has led to development of several innovative products. With surface engineering of bio-implants, the market has been flourished with sustainable implants. These not only help in expedited healing, but also provide solutions for a diverse range of consumers, including aging patients and those suffering from osteoporosis and diabetes. One such example is UV-treated bio implants, developed by a team of UCLA School of Dentistry researchers in November 2023. The ultraviolet light treated titanium implants are expected to hold a significant bio implants market share in coming years. It exhibits up to 60% bacterial susceptibility and highly accurate bone integration. It also reduces the risk of complications, side effects while promoting faster healing.
Other factors that impact the market dynamics consist of the growing adoption of bioimplants therapies in the healthcare sector, increased patient awareness, and improvements in the regulatory landscape. Moreover, emphasis on improving the healthcare infrastructure for enhanced patient experience also impact the market scenario positively.
Global Bio Implants Market Trends
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
Technological Advancements
Due to the technological advancements occurring in the bio implant materials and manufacturing processes, the market has expanded significantly. The biocompatible material which can be integrated seamlessly with human tissue has revolutionized the field by reducing the risk of rejection and extending the lifespan of implants.
Growing Demand for Orthopedic Implants
The surge in demand for bio implants has increased due to the rise in musculoskeletal disorders like osteoporosis and arthritis, especially in the geriatric population. The implants are used to restore mobility in joint replacements, and therefore, improve quality of life for millions of people. With the growing geriatric population and increasing prevalence of orthopedic disorders, the bio implants market demand is estimated to elevate in the forecast period.
Increase in Cardiovascular Implants
The cardiovascular implants including stents, pacemakers, and structural cardiac implants are in demand as the global burden of cardiovascular diseases is increasing. The rise in lifestyle changes, aging population, and an increased prevalence of diabetes and hypertension results in cardiovascular diseases, hence, appropriate intervention is a key area of attention amongst researchers.
Expansion into Emerging Economies
The improving healthcare infrastructure, rising healthcare expenditures, and growing public awareness of advanced medical treatments have accelerated the expansion of the market share into emerging economies.
Global Bio Implants Market Segmentation
Bio Implants Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Global Bio Implants Market Overview
Biomedical implants or bio implants are medical devices injected or surgically implanted into the body to support, repair, replace, or enhance the existing biological structure. According to the World Health Organisation (WHO), chronic diseases account for 41 million deaths annually. The rising burden of chronic diseases is anticipated to bolster the market growth in the future. In addition, technical advancements such as advent of biocompatible materials, surge in research initiatives, as well as increasing application of bioimplants in multiple domains including cardiology, neurology and dentistry among others is projected to bolster the bio implants market growth in the forecast period.
In October 2023, Evonik introduced an innovative carbon-fiber reinforced PEEK filament to be used in 3D printing of medical implants. VESTAKEEP® filament featured 12% and 20% carbon fiber content, offering high strength, flexibility and ductility. Applied as 3D medical implants, it can be used in bone plates and other reconstructive prostheses. Growing utilisation of smart materials in developing compatible, lightweight, and durable implants in one of the most significant trends in the market, helping to curb the rising bio implants market demand.
In recent years, technical advancements and a better understanding of human anatomy has led to development of several innovative products. With surface engineering of bio-implants, the market has been flourished with sustainable implants. These not only help in expedited healing, but also provide solutions for a diverse range of consumers, including aging patients and those suffering from osteoporosis and diabetes. One such example is UV-treated bio implants, developed by a team of UCLA School of Dentistry researchers in November 2023. The ultraviolet light treated titanium implants are expected to hold a significant bio implants market share in coming years. It exhibits up to 60% bacterial susceptibility and highly accurate bone integration. It also reduces the risk of complications, side effects while promoting faster healing.
Other factors that impact the market dynamics consist of the growing adoption of bioimplants therapies in the healthcare sector, increased patient awareness, and improvements in the regulatory landscape. Moreover, emphasis on improving the healthcare infrastructure for enhanced patient experience also impact the market scenario positively.
Global Bio Implants Market Trends
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
Technological Advancements
Due to the technological advancements occurring in the bio implant materials and manufacturing processes, the market has expanded significantly. The biocompatible material which can be integrated seamlessly with human tissue has revolutionized the field by reducing the risk of rejection and extending the lifespan of implants.
Growing Demand for Orthopedic Implants
The surge in demand for bio implants has increased due to the rise in musculoskeletal disorders like osteoporosis and arthritis, especially in the geriatric population. The implants are used to restore mobility in joint replacements, and therefore, improve quality of life for millions of people. With the growing geriatric population and increasing prevalence of orthopedic disorders, the bio implants market demand is estimated to elevate in the forecast period.
Increase in Cardiovascular Implants
The cardiovascular implants including stents, pacemakers, and structural cardiac implants are in demand as the global burden of cardiovascular diseases is increasing. The rise in lifestyle changes, aging population, and an increased prevalence of diabetes and hypertension results in cardiovascular diseases, hence, appropriate intervention is a key area of attention amongst researchers.
Expansion into Emerging Economies
The improving healthcare infrastructure, rising healthcare expenditures, and growing public awareness of advanced medical treatments have accelerated the expansion of the market share into emerging economies.
Global Bio Implants Market Segmentation
Bio Implants Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
- Autografts
- Allografts
- Xenografts
- Cardiovascular Implants
- Orthopedic Implants
- Dental Implants
- Spinal implants
- Ophthalmic Implants
- Other Soft Tissue Implants
- Biomaterial Metal and Alloys
- Polymers
- Other Materials
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- aap Implantate AG
- Abbott Laboratories
- Bausch & Lomb Incorporated
- BIOTRONIK Inc.
- Edwards Lifesciences Corporation
- LifeNet Health
- MiMeDX
- Smith & Nephew PLC
- Zimmer Biomet
- Boston Scientific Corporation
- Stryker Corporation
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Bio Implants Market Overview
- 3.1 Global Bio Implants Market Historical Value (2018-2024)
- 3.2 Global Bio Implants Market Forecast Value (2025-2034)
- 4 Global Bio Implants Market Landscape*
- 4.1 Global Bio Implants Market: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Bio Implants Market: Product Landscape
- 4.2.1 Analysis by Product
- 4.2.2 Analysis by Platform
- 4.2.3 By Treatment Sample
- 5 Global Bio Implants Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Bio Implants Market Segmentation (218-2034)
- 6.1 Global Bio Implants Market (2018-2034) by Product
- 6.1.1 Market Overview
- 6.1.2 Autografts
- 6.1.3 Allografts
- 6.1.4 Xenografts
- 6.2 Global Bio Implants Market (2018-2034) by Application
- 6.2.1 Market Overview
- 6.2.2 Cardiovascular Implants
- 6.2.3 Orthopedic Implants
- 6.2.4 Dental Implants
- 6.2.5 Spinal implants
- 6.2.6 Ophthalmic Implants
- 6.2.7 Other Soft Tissue Implants
- 6.3 Global Bio Implants Market (2018-2034) by Material
- 6.3.1 Market Overview
- 6.3.2 Biomaterial Metal and Alloys
- 6.3.3 Polymers
- 6.3.4 Other Materials
- 6.4 Global Bio Implants Market (2018-2034) by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Bio Implants Market (218-2034)
- 7.1 North America Bio Implants Market (2018-2034) by Product
- 7.1.1 Market Overview
- 7.1.2 Autografts
- 7.1.3 Allografts
- 7.1.4 Xenografts
- 7.2 North America Bio Implants Market (2018-2034) by Application
- 7.2.1 Market Overview
- 7.2.2 Cardiovascular Implants
- 7.2.3 Orthopedic Implants
- 7.2.4 Dental Implants
- 7.2.5 Spinal implants
- 7.2.6 Ophthalmic Implants
- 7.2.7 Other Soft Tissue Implants
- 7.3 North America Bio Implants Market (2018-2034) by Material
- 7.3.1 Market Overview
- 7.3.2 Biomaterial Metal and Alloys
- 7.3.3 Polymers
- 7.3.4 Other Materials
- 7.4 North America Bio Implants Market (2018-2034) by Country
- 7.4.1 United States of America
- 7.4.2 Canada
- 8 Europe Bio Implants Market (218-2034)
- 8.1 Europe Bio Implants Market (2018-2034) by Product
- 8.1.1 Market Overview
- 8.1.2 Autografts
- 8.1.3 Allografts
- 8.1.4 Xenografts
- 8.2 Europe Bio Implants Market (2018-2034) by Application
- 8.2.1 Market Overview
- 8.2.2 Cardiovascular Implants
- 8.2.3 Orthopedic Implants
- 8.2.4 Dental Implants
- 8.2.5 Spinal implants
- 8.2.6 Ophthalmic Implants
- 8.2.7 Other Soft Tissue Implants
- 8.3 Europe Bio Implants Market (2018-2034) by Material
- 8.3.1 Market Overview
- 8.3.2 Biomaterial Metal and Alloys
- 8.3.3 Polymers
- 8.3.4 Other Materials
- 8.4 Europe Bio Implants Market (2018-2034) by Country
- 8.4.1 United Kingdom
- 8.4.2 Germany
- 8.4.3 France
- 8.4.4 Italy
- 8.4.5 Others
- 9 Asia Pacific Bio Implants Market (218-2034)
- 9.1 Asia Pacific Bio Implants Market (2018-2034) by Product
- 9.1.1 Market Overview
- 9.1.2 Autografts
- 9.1.3 Allografts
- 9.1.4 Xenografts
- 9.2 Asia Pacific Bio Implants Market (2018-2034) by Application
- 9.2.1 Market Overview
- 9.2.2 Cardiovascular Implants
- 9.2.3 Orthopedic Implants
- 9.2.4 Dental Implants
- 9.2.5 Spinal implants
- 9.2.6 Ophthalmic Implants
- 9.2.7 Other Soft Tissue Implants
- 9.3 Asia Pacific Bio Implants Market (2018-2034) by Material
- 9.3.1 Market Overview
- 9.3.2 Biomaterial Metal and Alloys
- 9.3.3 Polymers
- 9.3.4 Other Materials
- 9.4 Asia Pacific Bio Implants Market (2018-2034) by Country
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 ASEAN
- 9.4.5 Australia
- 9.4.6 Others
- 10 Latin America Bio Implants Market (218-2034)
- 10.1 Latin America Bio Implants Market (2018-2034) by Product
- 10.1.1 Market Overview
- 10.1.2 Autografts
- 10.1.3 Allografts
- 10.1.4 Xenografts
- 10.2 Latin America Bio Implants Market (2018-2034) by Application
- 10.2.1 Market Overview
- 10.2.2 Cardiovascular Implants
- 10.2.3 Orthopedic Implants
- 10.2.4 Dental Implants
- 10.2.5 Spinal implants
- 10.2.6 Ophthalmic Implants
- 10.2.7 Other Soft Tissue Implants
- 10.3 Latin America Bio Implants Market (2018-2034) by Material
- 10.3.1 Market Overview
- 10.3.2 Biomaterial Metal and Alloys
- 10.3.3 Polymers
- 10.3.4 Other Materials
- 10.4 Latin America Bio Implants Market (2018-2034) by Country
- 10.4.1 Brazil
- 10.4.2 Argentina
- 10.4.3 Mexico
- 10.4.4 Others
- 11 Middle East and Africa Bio Implants Market (218-2034)
- 11.1 Middle East and Africa Bio Implants Market (2018-2034) by Product
- 11.1.1 Market Overview
- 11.1.2 Autografts
- 11.1.3 Allografts
- 11.1.4 Xenografts
- 11.2 Middle East and Africa Bio Implants Market (2018-2034) by Application
- 11.2.1 Market Overview
- 11.2.2 Cardiovascular Implants
- 11.2.3 Orthopedic Implants
- 11.2.4 Dental Implants
- 11.2.5 Spinal implants
- 11.2.6 Ophthalmic Implants
- 11.2.7 Other Soft Tissue Implants
- 11.3 Middle East and Africa Bio Implants Market (2018-2034) by Material
- 11.3.1 Market Overview
- 11.3.2 Biomaterial Metal and Alloys
- 11.3.3 Polymers
- 11.3.4 Other Materials
- 11.4 Middle East and Africa Bio Implants Market (2018-2034) by Country
- 11.4.1 Saudi Arabia
- 11.4.2 United Arab Emirates
- 11.4.3 Nigeria
- 11.4.4 South Africa
- 11.4.5 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Partnership and Collaborations Analysis
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 aap Implantate AG
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Abbott Laboratories
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Bausch & Lomb Incorporated
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 BIOTRONIK Inc.
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Edwards Lifesciences Corporation
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 LifeNet Health
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 MiMeDX
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Smith & Nephew PLC
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Zimmer Biomet
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Boston Scientific Corporation
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Stryker Corporation
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 18 Global Bio Implants Market – Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.